Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.63 USD | +1.11% | +3.12% | +7.40% |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 444.8 | 121.3 | 136.4 | - | - |
Enterprise Value (EV) 1 | 258.2 | 3.326 | 23.35 | -104.3 | 53.05 |
P/E ratio | -5.79 x | -1.59 x | -1.89 x | -1.89 x | -2.26 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | - | - | 415 x | 8.06 x |
EV / Revenue | - | - | - | -317 x | 3.13 x |
EV / EBITDA | -3.75 x | -0.04 x | -0.22 x | 0.79 x | -0.34 x |
EV / FCF | -3.91 x | -0.05 x | -0.26 x | 1.06 x | -0.54 x |
FCF Yield | -25.6% | -2,136% | -382% | 94.1% | -186% |
Price to Book | 2.35 x | 1.04 x | 3.3 x | 3.86 x | 3.95 x |
Nbr of stocks (in thousands) | 35,581 | 35,877 | 37,584 | - | - |
Reference price 2 | 12.50 | 3.380 | 3.630 | 3.630 | 3.630 |
Announcement Date | 3/21/23 | 3/26/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | 0.3286 | 16.93 |
EBITDA 1 | - | - | -68.81 | -88.47 | -104.8 | -131.5 | -156.7 |
EBIT 1 | - | -42.41 | -68.88 | -88.87 | -93.23 | -109.7 | -119.1 |
Operating Margin | - | - | - | - | - | -33,401.32% | -703.65% |
Earnings before Tax (EBT) 1 | - | -43.28 | -68.3 | -82.64 | -88.37 | -110.7 | -135.6 |
Net income 1 | -28.55 | -43.28 | -68.3 | -82.64 | -86.84 | -105.4 | -115 |
Net margin | - | - | - | - | - | -32,078.2% | -679.29% |
EPS 2 | -21.16 | -28.26 | -2.160 | -2.130 | -1.918 | -1.925 | -1.607 |
Free Cash Flow 1 | - | -39.22 | -66.07 | -71.04 | -89.1 | -98.13 | -98.45 |
FCF margin | - | - | - | - | - | -29,864.46% | -581.46% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 10/8/21 | 3/25/22 | 3/21/23 | 3/26/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -12.98 | -15.33 | -17.04 | -17.64 | -18.87 | -20.78 | -21.91 | -22.32 | -23.86 | -21.42 | -22.65 | -23.28 | -23.9 | -23.9 | -25.7 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -12.98 | -15.33 | -17.02 | -17.5 | -18.46 | -19.8 | -20.17 | -20.5 | -22.17 | -19.94 | -22.4 | -21.55 | -22.44 | -23.6 | -25.3 |
Net income 1 | -12.98 | -15.33 | -17.02 | -17.5 | -18.46 | -19.8 | -20.17 | -20.5 | -22.17 | -19.94 | -22 | -21.31 | -22.07 | -23.6 | -25.3 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -8.280 | -0.5800 | -0.6000 | -0.5300 | -0.4800 | -0.5100 | -0.5200 | -0.5300 | -0.5700 | -0.5000 | -0.5475 | -0.4475 | -0.4638 | -0.4700 | -0.4650 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/25/22 | 5/12/22 | 8/8/22 | 11/10/22 | 3/21/23 | 5/10/23 | 8/8/23 | 11/7/23 | 3/26/24 | 5/7/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | - | 91.4 | 187 | 118 | 113 | 241 | 83.4 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -39.2 | -66.1 | -71 | -89.1 | -98.1 | -98.4 |
ROE (net income / shareholders' equity) | - | - | -48.5% | -54.1% | -121% | -224% | -194% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | 5.310 | 3.240 | 1.100 | 0.9400 | 0.9200 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 0.2 | 0.92 | 0.67 | 1.69 | 2.03 | 3.36 |
Capex / Sales | - | - | - | - | - | 618.23% | 19.82% |
Announcement Date | 10/8/21 | 3/25/22 | 3/21/23 | 3/26/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.40% | 135M | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- VIGL Stock
- Financials Vigil Neuroscience, Inc.